Used as an intermediate in the synthesis of fluorinated pharmaceutical compounds, particularly in the development of selective kinase inhibitors and central nervous system agents. Its structure supports the construction of bioactive molecules where fluorine substitution enhances metabolic stability and binding affinity. Commonly employed in medicinal chemistry for building blocks in drug discovery programs targeting inflammation, neurological disorders, and oncology. Also utilized in the preparation of radiolabeled analogs for positron emission tomography (PET) imaging due to the presence of fluorine, enabling non-invasive diagnostic applications.